Our Members
AlternOx Scientific is a newly established bio-pharma company developing novel, proprietary inhibitors of the enzyme alternative oxidase – to treat a wide range of multi-drug and multi-compound resistant species of fungi that now threaten human health and food security worldwide.
Fungicides play a key strategic role in both human medical treatments and crop disease control, but increasing resistance to existing solutions threatens their ongoing effectiveness. Novel compounds developed at the University of Sussex directly address this escalating challenge and, when applied alone or in combination with existing antifungal agents, are set to prevent the development of fungal resistance.
In clinical settings this could help to minimise the risk of infection from life-threatening fungal infections, while in agriculture it can help reduce application cycles and environmental damage and, as a result, increase crop yield.